Originally, BC was broadly classified into hormone receptor-positive BC and hormone receptor-negative, but with the advancement in diagnostics and molecular biology, a more complex and heterogeneous nature of BC was revealed [14]. This evidence concerns the gene NR4A1 and breast cancer.